Photo Gallery

Login

Search

News & Updation

  • WJPPS JULY ISSUE PUBLISHED
  • JULY 2017 Issue has been successfully launched on 1 July 2017

  • ICV
  • WJPPS Rank with Index Copernicus Value 52.51 due to high reputation at International Level

  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from 6.041 to 6.647 due to high quality Publication at International Level

  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  

Abstract

COMBINATION THERAPEUTIC INFLUENCE OF ASPIRIN AND RIVASTIGMINE ON SCOPOLAMINE INDUCED ALZHEIMER’S IN WISTAR RAT

Sudhakar Pachiappan*, Suchithra K. B., Suganeswari M. and Preetu Shukla K. M.

ABSTRACT

Objective: To investigate the combination therapeutic influence of aspirin and rivastigmine on scopolamine induced alzheimer’s in rats. Materials and Methods: Twenty four male Albino Wistar Rats were enrolled in this study and are divided into 4 groups (six each). Memory impairment was induced by administration of scopolamine (1 mg/kg intraperitoneally). Group-I; receives normal saline, Group-II; receives scopolamine (1.0mg/kg/day i. p.), Group-III; Rivastigmine (0.3mg/kg/day p. o.) + Scopolamine (1.0 mg/kg day i. p.), Group-IV; Aspirin (6.75mg/kg/day p. o.) + Rivastigmine (0.3mg/kg/day p. o.) + Scopolamine (1.0 mg/kg/day i. p.) all the treatment carried out daily for 14 days. Cognitive and condition avoidance response was evaluated by using Morris Water Maze (MWM) and Pole climbing apparatus respectively. On 14th day brain was isolated for biochemical and Histopathological examination. Results: In this study, Rivastigmine and aspirin combination showed that significant increase in cognitive and conditions avoid response. Brain histological investigation of scopolamine injected rats showed neurodegeneration, Aβ plagues and odema. This combination improves biochemical parameters as well as in the histological feature of the brain as compare to the rivastigmine alone treated group. Conclusion: Aspirin and Rivastigmine combination possesses significant protective effect against neuroinflammation characterizing AD.

Keywords: Scopolamine, alzheimer’s, neuroinflammation, rivastigmine, aspirin.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More